Analyze Diet

A CONSORT-guided, randomized, double-blind, controlled pilot clinical trial of inhaled lidocaine for the treatment of equine asthma.

Abstract: There are limited options for treatment of the common disease, equine asthma. The aim of this study was to estimate the feasibility and potential efficacy of using nebulized lidocaine for treating equine asthma, while at the same time treating a separate cohort of asthmatic horses with inhaled budesonide. Nineteen horses with a history consistent with equine asthma were recruited from our referral population for a double-blind, randomized, controlled pilot clinical trial using Consolidated Standards of Reporting Trials (CONSORT) guidelines. After screening, 16 horses met the inclusion criteria for equine asthma and 13 horses actually completed the study. Horses were treated by their owners at home for 14 d before returning to our hospital for follow-up assessment. Interventions consisted of nebulization q12h for 14 d with 1.0 mg/kg body weight (BW) of lidocaine or corticosteroid treatment (nebulized budesonide 1 μg/kg, q12h). Clinical and tracheal mucus score, pulmonary function testing, and respiratory secretion cytology were assessed after 2 weeks of treatment to determine the outcome. Both lidocaine and budesonide cohorts had significant decreases ( < 0.05) in clinical score; the lidocaine cohort showed a significant decrease in bronchoalveolar lavage (BAL) neutrophil percentage and tracheal mucus score. Neither treatment resulted in significant changes in lung function parameters. No adverse events occurred. Lidocaine may be an effective and safe treatment for equine asthma in horses that cannot tolerate treatment with corticosteroids. Il existe des options limitées pour le traitement de la maladie répandue, l’asthme équin. Le but de cette étude était d’estimer la faisabilité et l’efficacité potentielle de l’utilisation de la lidocaïne nébulisée pour traiter l’asthme équin, tout en traitant en même temps une cohorte distincte de chevaux asthmatiques avec du budésonide inhalé. Dix-neuf chevaux ayant des antécédents compatibles avec l’asthme équin ont été recrutés dans notre population de référence pour un essai clinique pilote contrôlé, randomisé, en double aveugle, conformément aux directives CONSORT (). Après dépistage, 16 chevaux répondaient aux critères d’inclusion de l’asthme équin et 13 chevaux ont terminé l’étude. Les chevaux ont été traités par leurs propriétaires à domicile pendant 14 jours avant de retourner à notre hôpital pour une évaluation de suivi. Les interventions consistaient en une nébulisation deux fois par jour pendant 14 jours avec 1,0 mg/kg de poids corporel (PC) de lidocaïne ou un traitement aux corticostéroïdes (budésonide nébulisé 1 μg/kg, q12h). Le score clinique et de mucus trachéal, les tests de la fonction pulmonaire et la cytologie des sécrétions respiratoires ont été évalués après 2 semaines de traitement pour déterminer le résultat. Les cohortes de lidocaïne et de budésonide présentaient des diminutions significatives ( < 0,05) du score clinique; la cohorte de lidocaïne a montré une diminution significative du pourcentage de neutrophiles du lavage bronchoalvéolaire (BAL) et du score de mucus trachéal. Aucun des deux traitements n’a entraîné de changements significatifs dans les paramètres de la fonction pulmonaire. Aucun événement indésirable n’est survenu. La lidocaïne peut être un traitement efficace et sûr de l’asthme équin chez les chevaux qui ne tolèrent pas le traitement aux corticostéroïdes.(Traduit par Docteur Serge Messier).
Publication Date: 2022-04-08 PubMed ID: 35388235PubMed Central: PMC8978287
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Randomized Controlled Trial
  • Veterinary

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research aims to examine the potential effectiveness and feasibility of using nebulized lidocaine as a treatment for equine asthma, in comparison to inhaled budesonide. The study finds that both lidocaine and budesonide demonstrate notable improvements in clinical scores, with lidocaine showing a significant reduction in bronchoalveolar lavage (BAL) neutrophil percentage and tracheal mucus score.

Objective and Methodology

  • This study is designed as a consortium-guided, double-blind, randomized pilot clinical trial to explore new treatment methods for equine asthma, which currently has limited therapeutic options.
  • During the trial, 19 horses with equine asthma were randomly selected and segregated into two groups. One cohort was treated with nebulized lidocaine and the other with nebulized budesonide for a period of 14 days.
  • All treatments were conducted by their owners at their home, and the horses were brought back to the hospital for a post-treatment assessment after two weeks.

Outcome and Findings

  • At the end of the trial, it was observed that both cohorts of horses, treated with either lidocaine or budesonide, had significant decreases in their clinical scores.
  • More specifically, horses treated with lidocaine showcased a remarkable decrease in bronchoalveolar lavage (BAL) neutrophil percentage and tracheal mucus score.
  • However, there were no significant changes noticed in the lung function parameters of the horses after undergoing either treatment.
  • No adverse events were reported during the course of the study, suggesting that both lidocaine and budesonide were not associated with any safety risks.

Conclusion

  • The research concludes that lidocaine has the potential to be an effective and safe treatment for equine asthma, particularly for horses that are intolerant to corticosteroid treatment.
  • Despite the study not noting any significant changes in lung function parameters, the marked improvements in clinical scores and tracheal mucus score for the lidocaine cohort indicate a promising avenue for future exploration and more comprehensive studies.

Cite This Article

APA
Mahalingam-Dhingra A, Mazan MR, Bedenice D, Ceresia M, Minuto J, Deveney EF. (2022). A CONSORT-guided, randomized, double-blind, controlled pilot clinical trial of inhaled lidocaine for the treatment of equine asthma. Can J Vet Res, 86(2), 116-124.

Publication

ISSN: 1928-9022
NlmUniqueID: 8607793
Country: Canada
Language: English
Volume: 86
Issue: 2
Pages: 116-124

Researcher Affiliations

Mahalingam-Dhingra, Ananya
  • Clinical Sciences, Cummings School of Veterinary Medicine at Tufts University, North Grafton, Massachusetts, USA (Mahalingam-Dhingra, Mazan, Bedenice, Minuto); Pharmacology, Massachusetts College of Pharmacy and Health Sciences, Boston, Massachusetts, USA (Ceresia); Physics, Bridgewater State University, Bartlett College of Science and Mathematics, Bridgewater, Massachusetts, USA (Deveney).
Mazan, Melissa R
  • Clinical Sciences, Cummings School of Veterinary Medicine at Tufts University, North Grafton, Massachusetts, USA (Mahalingam-Dhingra, Mazan, Bedenice, Minuto); Pharmacology, Massachusetts College of Pharmacy and Health Sciences, Boston, Massachusetts, USA (Ceresia); Physics, Bridgewater State University, Bartlett College of Science and Mathematics, Bridgewater, Massachusetts, USA (Deveney).
Bedenice, Daniela
  • Clinical Sciences, Cummings School of Veterinary Medicine at Tufts University, North Grafton, Massachusetts, USA (Mahalingam-Dhingra, Mazan, Bedenice, Minuto); Pharmacology, Massachusetts College of Pharmacy and Health Sciences, Boston, Massachusetts, USA (Ceresia); Physics, Bridgewater State University, Bartlett College of Science and Mathematics, Bridgewater, Massachusetts, USA (Deveney).
Ceresia, Michelle
  • Clinical Sciences, Cummings School of Veterinary Medicine at Tufts University, North Grafton, Massachusetts, USA (Mahalingam-Dhingra, Mazan, Bedenice, Minuto); Pharmacology, Massachusetts College of Pharmacy and Health Sciences, Boston, Massachusetts, USA (Ceresia); Physics, Bridgewater State University, Bartlett College of Science and Mathematics, Bridgewater, Massachusetts, USA (Deveney).
Minuto, Jill
  • Clinical Sciences, Cummings School of Veterinary Medicine at Tufts University, North Grafton, Massachusetts, USA (Mahalingam-Dhingra, Mazan, Bedenice, Minuto); Pharmacology, Massachusetts College of Pharmacy and Health Sciences, Boston, Massachusetts, USA (Ceresia); Physics, Bridgewater State University, Bartlett College of Science and Mathematics, Bridgewater, Massachusetts, USA (Deveney).
Deveney, Edward F
  • Clinical Sciences, Cummings School of Veterinary Medicine at Tufts University, North Grafton, Massachusetts, USA (Mahalingam-Dhingra, Mazan, Bedenice, Minuto); Pharmacology, Massachusetts College of Pharmacy and Health Sciences, Boston, Massachusetts, USA (Ceresia); Physics, Bridgewater State University, Bartlett College of Science and Mathematics, Bridgewater, Massachusetts, USA (Deveney).

MeSH Terms

  • Administration, Inhalation
  • Animals
  • Asthma / drug therapy
  • Asthma / veterinary
  • Bronchoalveolar Lavage / veterinary
  • Budesonide / therapeutic use
  • Double-Blind Method
  • Horse Diseases / drug therapy
  • Horses
  • Humans
  • Lidocaine / therapeutic use

References

This article includes 33 references
  1. Pirie RS. Recurrent airway obstruction: a review.. Equine Vet J 2014 May;46(3):276-88.
    pubmed: 24164473doi: 10.1111/evj.12204google scholar: lookup
  2. Bond S, Léguillette R, Richard EA, Couetil L, Lavoie JP, Martin JG, Pirie RS. Equine asthma: Integrative biologic relevance of a recently proposed nomenclature.. J Vet Intern Med 2018 Nov;32(6):2088-2098.
    pmc: PMC6271326pubmed: 30294851doi: 10.1111/jvim.15302google scholar: lookup
  3. Bedenice D, Mazan MR, Hoffman AM. Association between cough and cytology of bronchoalveolar lavage fluid and pulmonary function in horses diagnosed with inflammatory airway disease.. J Vet Intern Med 2008 Jul-Aug;22(4):1022-8.
  4. Lavoie JP, Leclere M, Rodrigues N, Lemos KR, Bourzac C, Lefebvre-Lavoie J, Beauchamp G, Albrecht B. Efficacy of inhaled budesonide for the treatment of severe equine asthma.. Equine Vet J 2019 May;51(3):401-407.
    pmc: PMC6585971pubmed: 30203854doi: 10.1111/evj.13018google scholar: lookup
  5. Becker DE, Reed KL. Essentials of local anesthetic pharmacology.. Anesth Prog 2006 Fall;53(3):98-108; quiz 109-10.
  6. Ortiz MP, Godoy MC, Schlosser RS, Ortiz RP, Godoy JP, Santiago ES, Rigo FK, Beck V, Duarte T, Duarte MM, Menezes MS. Effect of endovenous lidocaine on analgesia and serum cytokines: double-blinded and randomized trial.. J Clin Anesth 2016 Dec;35:70-77.
  7. Lim KG, Rank MA, Hahn PY, Keogh KA, Morgenthaler TI, Olson EJ. Long-term safety of nebulized lidocaine for adults with difficult-to-control chronic cough: a case series.. Chest 2013 Apr;143(4):1060-1065.
    pubmed: 23238692doi: 10.1378/chest.12-1533google scholar: lookup
  8. Nafe LA, Guntur VP, Dodam JR, Lee-Fowler TM, Cohn LA, Reinero CR. Nebulized lidocaine blunts airway hyper-responsiveness in experimental feline asthma.. J Feline Med Surg 2013 Aug;15(8):712-6.
    pubmed: 23392613doi: 10.1177/1098612x13476705google scholar: lookup
  9. Wilson ME, Berney C, Behan AL, Robinson NE. The effect of intravenous lidocaine infusion on bronchoalveolar lavage cytology in equine recurrent airway obstruction.. J Vet Intern Med 2012 Nov-Dec;26(6):1427-32.
  10. Schulz KF, Altman DG, Moher D. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials.. BMC Med 2010 Mar 24;8:18.
    pmc: PMC2860339pubmed: 20334633doi: 10.1186/1741-7015-8-18google scholar: lookup
  11. Tesarowski DB, Viel L, McDonell WN. Pulmonary function measurements during repeated environmental challenge of horses with recurrent airway obstruction (heaves).. Am J Vet Res 1996 Aug;57(8):1214-9.
    pubmed: 8836377
  12. Lavoie JP, Bullone M, Rodrigues N, Germim P, Albrecht B, von Salis-Soglio M. Effect of different doses of inhaled ciclesonide on lung function, clinical signs related to airflow limitation and serum cortisol levels in horses with experimentally induced mild to severe airway obstruction.. Equine Vet J 2019 Nov;51(6):779-786.
    pmc: PMC7379559pubmed: 30854685doi: 10.1111/evj.13093google scholar: lookup
  13. Gerber V, Lindberg A, Berney C, Robinson NE. Airway mucus in recurrent airway obstruction--short-term response to environmental challenge.. J Vet Intern Med 2004 Jan-Feb;18(1):92-7.
  14. Dixon CE, Bedenice D, Mazan MR. Comparison of Flowmetric Plethysmography and Forced Oscillatory Mechanics to Measure Airway Hyperresponsiveness in Horses.. Front Vet Sci 2020;7:511023.
    pmc: PMC7937713pubmed: 33693040doi: 10.3389/fvets.2020.511023google scholar: lookup
  15. Pacheco AP, Paradis MR, Hoffman AM, Hermida P, Sanchez A, Nadeau JA, Tufts M, Mazan MR. Age effects on blood gas, spirometry, airway reactivity, and bronchoalveolar lavage fluid cytology in clinically healthy horses.. J Vet Intern Med 2014 Mar-Apr;28(2):603-8.
    pmc: PMC4857999pubmed: 24528225doi: 10.1111/jvim.12318google scholar: lookup
  16. Mazan MR, Hoffman AM, Manjerovic N. Comparison of forced oscillation with the conventional method for histamine bronchoprovocation testing in horses.. Am J Vet Res 1999 Feb;60(2):174-80.
    pubmed: 10048547
  17. Mazan MR, Lascola K, Bruns SJ, Hoffman AM. Use of a novel one-nostril mask-spacer device to evaluate airway hyperresponsiveness (AHR) in horses after chronic administration of albuterol.. Can J Vet Res 2014 Jul;78(3):214-20.
    pmc: PMC4068413pubmed: 24982553
  18. Hoffman AM, Mazan MR, Ellenberg S. Association between bronchoalveolar lavage cytologic features and airway reactivity in horses with a history of exercise intolerance.. Am J Vet Res 1998 Feb;59(2):176-81.
    pubmed: 9492932
  19. Sierra-Rodriguez T, Groover ES, Lascola KM, Mora-Pereira M, Lee YH, Duran SH, Ravis WR, Spangler E, Hathcock T, Wooldridge AA. Clinical Feasibility and Airway Deposition of Nebulized Voriconazole in Healthy Horses.. J Equine Vet Sci 2020 Nov;94:103246.
    pubmed: 33077094doi: 10.1016/j.jevs.2020.103246google scholar: lookup
  20. de Wasseige S, Picotte K, Lavoie JP. Nebulized dexamethasone sodium phosphate in the treatment of horses with severe asthma.. J Vet Intern Med 2021 May;35(3):1604-1611.
    pmc: PMC8162592pubmed: 33817859doi: 10.1111/jvim.16113google scholar: lookup
  21. Cohen J. A power primer.. Psychol Bull 1992 Jul;112(1):155-9.
    pubmed: 19565683doi: 10.1037//0033-2909.112.1.155google scholar: lookup
  22. Groeben H, Grosswendt T, Silvanus M, Beste M, Peters J. Lidocaine inhalation for local anaesthesia and attenuation of bronchial hyper-reactivity with least airway irritation. Effect of three different dose regimens.. Eur J Anaesthesiol 2000 Nov;17(11):672-9.
  23. Elfenbein JR, Robertson SA, MacKay RJ, KuKanich B, Sanchez L. Systemic and anti-nociceptive effects of prolonged lidocaine, ketamine, and butorphanol infusions alone and in combination in healthy horses.. BMC Vet Res 2014;10 Suppl 1(Suppl 1):S6.
    pmc: PMC4123056pubmed: 25238633doi: 10.1186/1746-6148-10-s1-s6google scholar: lookup
  24. Cook VL, Blikslager AT. Use of systemically administered lidocaine in horses with gastrointestinal tract disease.. J Am Vet Med Assoc 2008 Apr 15;232(8):1144-8.
    pubmed: 18412523doi: 10.2460/javma.232.8.1144google scholar: lookup
  25. Tappenbeck K, Hoppe S, Reichert C, Feige K, Huber K. In vitro effects of lidocaine on contractility of circular and longitudinal equine intestinal smooth muscle.. Vet J 2013 Oct;198(1):170-5.
    pubmed: 23973159doi: 10.1016/j.tvjl.2013.07.027google scholar: lookup
  26. Van Der Wal S, Vaneker M, Steegers M, Van Berkum B, Kox M, Van Der Laak J, Van Der Hoeven J, Vissers K, Scheffer GJ. Lidocaine increases the anti-inflammatory cytokine IL-10 following mechanical ventilation in healthy mice.. Acta Anaesthesiol Scand 2015 Jan;59(1):47-55.
    pubmed: 25312651doi: 10.1111/aas.12417google scholar: lookup
  27. Honarmand A, Safavi M. Beclomethasone inhaler versus intravenous lidocaine in the prevention of postoperative airway and throat complaints: a randomized, controlled trial.. Ann Saudi Med 2008 Jan-Feb;28(1):11-6.
    pmc: PMC6074231pubmed: 18299653doi: 10.5144/0256-4947.2008.11google scholar: lookup
  28. Hunt LW, Frigas E, Butterfield JH, Kita H, Blomgren J, Dunnette SL, Offord KP, Gleich GJ. Treatment of asthma with nebulized lidocaine: a randomized, placebo-controlled study.. J Allergy Clin Immunol 2004 May;113(5):853-9.
    pubmed: 15131566doi: 10.1016/j.jaci.2004.02.039google scholar: lookup
  29. Chong CF, Chen CC, Ma HP, Wu YC, Chen YC, Wang TL. Comparison of lidocaine and bronchodilator inhalation treatments for cough suppression in patients with chronic obstructive pulmonary disease.. Emerg Med J 2005 Jun;22(6):429-32.
    pmc: PMC1726806pubmed: 15911951doi: 10.1136/emj.2004.015719google scholar: lookup
  30. Takekawa K, Yoshimi S, Kinoshita Y. Effects of intravenous lidocaine prior to intubation on postoperative airway symptoms.. J Anesth 2006;20(1):44-7.
    pubmed: 16421677doi: 10.1007/s00540-005-0363-8google scholar: lookup
  31. Rush BR, Raub ES, Thomsen MM, Davis EG, Matson CJ, Hakala JE. Pulmonary function and adrenal gland suppression with incremental doses of aerosolized beclomethasone dipropionate in horses with recurrent airway obstruction.. J Am Vet Med Assoc 2000 Aug 1;217(3):359-64.
    pubmed: 10935040doi: 10.2460/javma.2000.217.359google scholar: lookup
  32. Gray BP, Biddle S, Pearce CM, Hillyer L. Detection of fluticasone propionate in horse plasma and urine following inhaled administration.. Drug Test Anal 2013 May;5(5):306-14.
    pubmed: 22514113doi: 10.1002/dta.1329google scholar: lookup
  33. US Food and Drug Administration. FDA approves Aservo EquiHaler (Ciclesonide) for severe equine asthma. .

Citations

This article has been cited 2 times.
  1. Minuto J, Bedenice D, Ceresia M, Zaghloul I, Böhlke M, Mazan MR. Clinical effects and pharmacokinetics of nebulized lidocaine in healthy horses.. Front Vet Sci 2022;9:984108.
    doi: 10.3389/fvets.2022.984108pubmed: 36187809google scholar: lookup
  2. Klier J, Fuchs S, Winter G, Gehlen H. Inhalative Nanoparticulate CpG Immunotherapy in Severe Equine Asthma: An Innovative Therapeutic Concept and Potential Animal Model for Human Asthma Treatment.. Animals (Basel) 2022 Aug 16;12(16).
    doi: 10.3390/ani12162087pubmed: 36009677google scholar: lookup